InvestorsHub Logo
Followers 1078
Posts 80333
Boards Moderated 8
Alias Born 03/10/2009

Re: None

Friday, 04/29/2022 6:41:33 AM

Friday, April 29, 2022 6:41:33 AM

Post# of 14
CapitalGainsReport: New Report Suggest Healthcare Tech Will Lead Fourth Industrial Revolution (WHSI, BKSY, SENS, GBS, GMVD, BEAT)
04/28/2022 | 05:59am EDT
share with twitter
share with LinkedIn
share with facebook
Forbes reports, "Healthcare technology can drive the Fourth Industrial Revolution." Some of the largest capital gains throughout history have been made on the backs of major industrial innovations.

A BRIEF HISTORY OF INDUSTRIAL REVOLUTIONS

-The First Industrial Revolution used water and steam power to mechanize production.

-The Second used electric power to create mass production.

-The Third used electronics and information technology to automate production.

THE FOURTH INDUSTRIAL REVOLUTION

The Fourth Industrial Revolution is building on the Third, the digital revolution that has been occurring since the middle of the last century. It is characterized by a fusion of technologies that is blurring the lines between the physical, digital, and biological spheres.

Healthcare Technology to Drive This New Revolution

While digital disruption touches all industries. Many see healthcare as a lead vertical for this acceleration in industry. Kelly Feist of Forbes online says, "When I look at the technologies associated with this Fourth Industrial Revolution, I see so much potential application in meeting healthcare's Quadruple Aim with predictive analytics, AI, the Internet of Things (IoT) and even 3-D printing. These fundamental technologies will help us speed up and improve the quality of care as well as change the overall model to one that supports a wellness-first shift. Already, AI is helping spot patterns from data, interpret the results and make smart recommendations to help clinicians. Today, wearable IoT plays a role in monitoring patients' conditions outside the hospital in an often home-based, patient-preferred environment, allowing continual oversight at lower costs."

Wearable Health Solutions (OTCMKTS: WHSI) is one company with IoT-based technology that is leading the way in the PERS (Personal Emergency Response Systems) market. Its telehealth-ready iHelp device allows a physician or family members to remotely monitor a person's vitals as well as track medications and more.

WHSI recently filed an 8K with the SEC on Tuesday. The filing contained multiple catalysts that could positively influence WHSI's share valuation in the near and long term.

1.Uplisting News- the company is now in the process of and is now preparing its application to uplist. When a company uplists from the pink sheets it provides investors the peace of mind that comes with increased regulation, transparency and disclosure. This can translate to:

-Lower Cost of Capital-that can in turn accelerate the company's growth and increase margins.

-Analyst Coverage- uplisting allows analysts to cover the stock and this is important because analyst coverage can lead to:

-Institutional Investment

-High-Net-Worth Individual Investors

-Increased Liquidity and Valuation- all of the above factors can lead to increased interest in the stock on all levels, and this influx of interest can be a force multiplier.

2. Newly Updated Websites- The newly updated sites bring more to the table than might meet the eye at first glance. In addition to looking professional and more polished than previous iterations; investors, buyers, and dealers will find them much more informationally robust. Investors familiar with WHSI may be able to infer the next logical conclusion...the iHelp Max 4G launch.

The launch would be another catalyst for share valuation.

For the fiscal year ending June 30th, 2021, WHSI reported some 8,000 end users plus an order book of about 2,000+ potential activations, which earned the company record revenues ($1.3 million) in 2021.

Launching this new device could lead to a consecutive year of record sales. Start your research on WHSI today.

GBS Inc (NASDAQ:GBS) - The company has not been in the news for some weeks now but it is necessary to note that earlier on in the month on April 4 there was a significant development that investors ought to know about. It emerged that the company had been given the approval from the institutional review board to start enrolling subjects meant for the time course glucose evaluation study.

The study in question was meant for clinical validation of the time course with regards to glucose. At this point in time, it may be a good idea for investors to keep an eye on upcoming news with regards to GBS.

G Medical Innovations Holdings Ltd (NASDAQ:GMVD) - The telehealth, remote patient monitoring, and medical devices company G Medical Innovations Holdings Ltd was in the news cycle back on April 20 following a key announcement.

At the time, the company announced that it had been successful in concluding the private placement of its shares with institutional investors, which is focused on the healthcare sector. The company sold as many as 5,000,000 ordinary shares to go along with warrants that entitle the holder to pick up 6,250,000 shares. G Medical Innovations Holdings managed to bring in $7.5 million in gross proceeds.

Heartbeam Inc (NASDAQ:BEAT) - In Q4, the net loss came in at $2.1 million, compared to a net loss of $335,000 for the fourth quarter of 2020, and $4.4 million for the full year 2021 compared to $1.1 million in the year-ago period. Cash totaled $13.2 million as of December 31, 2021, compared to $795,000 as of September 30, 2021 and $24,000 as of December 31, 2020.

Research and development expenses for the recent quarter were $96,000, compared to $47,000 for the fourth quarter of 2020.

Senseonics Holdings Inc (NYSEAMERICAN:SENS) - The company is all set to report its first-quarter 2022 financial results after market close on Tuesday, May 10, 2022.

Recently, the company announced the first commercial patient has been implanted with Eversense® E3, kicking off the launch of the next-generation CGM System in the U.S. The Eversense E3 Sensor was approved by the FDA in February and is the longest-lasting CGM available in the U.S.

BlackSky (NYSE:BKSY) - Last but not least, it is the BlackSky stock that could be tracked by investors at this point in time. Back on April 21, the company had come into focus after it announced that it had been successful in upgrading its site monitoring capabilities with the addition of new imaging as well as for analytics features.

BlackSky noted that these features are going to help in providing customers with the services that they often need. It remains to be seen if the BlackSky stock can come into focus among investors in the coming days.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. Capital Gains Report 'CGR' is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated three thousand dollars per month via wire transfer by Wearable Health Solutions, Inc. to produce and syndicate content related to WHSI. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.

CONTACT: To educate and attract more investors contact us at:

Mark McKelvie

mark@capitalgainsreport.com

(754) 233-0966

.

STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS

http://investorshub.advfn.com/boards/board.aspx?board_id=19627

My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GBS News